Skip to content
Screener

Reported July 29, 2026 · Before market open

Revenue$5.3BBeat by $31.3M
Adjusted EPS$1.13Beat by $0.09
Revenue estimate$5.3B
EPS estimate$1.04
We delivered record orders and backlog in the second quarter, with orders growth across every segment, demonstrating strong commercial execution, including the adoption of new products. In Patient Care Solutions, while we are focused on returning the business to growth and profitability, we are reviewing strategic options to maximize its long-term value. Our continued investment in precision innovation is expanding our addressable markets, strengthening our competitive position and supporting durable short-and long-term growth.
Peter Arduini

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$5.3B
EPS estimate$1.21

Financials

Q2 2026

Income statement

See full
Revenue$5.3B+5.8%
Gross profit$2.2B+9.8%
Operating income$739.0M+13.0%
Net income$561.0M+15.4%
EPS (diluted)$1.24+17.0%

Balance sheet

See full
Total debt$10.5B-1.6%
Total equity$11.0B+13.0%
Total assets$37.2B+4.9%

Cash flow

See full
Operating cash flow$168.0M+78.7%
CapEx$100.0M+16.3%
Free cash flow$68.0M+750%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$33.11B-2.3%
P/E16.7×+1.6×
P/S1.6×-0.1×

Profitability

See full
Gross margin39.5%-2.0pp
Operating margin12.9%-1.0pp
Net margin9.3%-1.9pp
FCF margin7.4%-0.4pp

Returns & leverage

See full
Return on equity19.2%-6.4pp
Debt / equity-0.1×
Current ratio1.3×+0.1×

Segments

By segment

See full
PDx$843.0M+15.6%
PCS$675.0M-13.2%

By product

See full
Service$1.9B+7.7%

FAQ

When did GE HealthCare Technologies report Q2 2026 earnings?
GE HealthCare Technologies (GEHC) reported Q2 2026 earnings on July 29, 2026 before market open.
What were GE HealthCare Technologies's Q2 2026 revenue and EPS?
GE HealthCare Technologies reported revenue of $5.3B and adjusted eps of $1.13 for Q2 2026.
Did GE HealthCare Technologies beat estimates in Q2 2026?
Revenue beat the consensus estimate of $5.3B by $31.3M. EPS beat the consensus estimate of $1.04 by $0.09.
How did GE HealthCare Technologies's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.8% from $5.0B a year earlier.
Where can I find GE HealthCare Technologies's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001932393-26-000045) and the 10-Q periodic report (0001932393-26-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.